Charles River   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Wilmington MA United States (1947)
Status: No NME R&D (1947)

Organization Overview

First Clinical Trial
2007
NCT01161654
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Charles River Analytics | Charles River Biopharmaceutical Services GmbH | Charles River Clinical Research | Charles River Clinical Services Edinburgh Ltd and CR Laboratories Preclinical Services Ltd | Charles River Clinical Services, Edinburgh, UK | Charles River Clinical Services Northwest | Charles River Clinical Services Northwest Inc. | Charles River Clinical Services Northwest, Inc. | Charles River Labs | Charles River Northwestern Kinetics | Charles River Northwest Kinetics